Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Sep 1;85(9):1340–1346. doi: 10.1054/bjoc.2001.2079

Detection of MAGE-A3 in breast cancer patients’ sentinel lymph nodes

R A Wascher 1, P J Bostick 1,2, K T Huynh 1, R Turner 3, K Qi 4, A E Giuliano 2, D S B Hoon 1
PMCID: PMC2375232  PMID: 11720472

Abstract

The detection of occult metastatic breast cancer cells by RT-PCR is limited by the poor specificity of most tumour mRNA markers. MAGE-A3 is a highly specific tumour mRNA marker that is not expressed in non-cancer cells. This study assesses MAGE-A3 mRNA as a molecular marker for the detection of tumour cells in the sentinel lymph nodes (SLN) of breast cancer patients. Serial frozen sections of SLN (n= 121) were obtained from 77 AJCC (American Joint Committee on Cancer) Stage I–IIIA breast cancer patients. MAGE-A3 mRNA analysis of SLN was performed by RT-PCR and Southern blot analysis. Tumour cells were detected in 48 of 121 (40%) SLN from 77 patients by H&E or IHC staining, and 35 of 77 (45%) patients, overall, had histopathologically (H&E and/or IHC) positive SLN. Among histopathologically negative SLN, 28 of 73 (38%) SLN were MAGE-A3 mRNA positive by RT-PCR. Overall, 41 of 77 (53%) patients and 50 of 121 (41%) SLN were positive for MAGE-A3. MAGE-A3 mRNA expression in the SLN occurred more frequently with infiltrating lobular carcinoma (P< 0.001) than with infiltrating ductal carcinoma, adding further evidence of possible phenotypic differences between these 2 subtypes of breast cancer. Due to its high specificity, MAGE-A3 mRNA is a potentially useful marker for detecting breast cancer cells in the SLN. One half of breast tumours expressed MAGE-A3 mRNA, which has important potential implications for antigen-specific targeted immunotherapy. © 2001 Cancer Research Campaign

Keywords: breast cancer, MAGE-A3, micrometastases, RT-PCR, sentinel lymph node

Full Text

The Full Text of this article is available as a PDF (95.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barth A., Craig P. H., Silverstein M. J. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer. 1997 May 15;79(10):1918–1922. [PubMed] [Google Scholar]
  2. Bentz J. S., Yassa N., Clayton F. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Mod Pathol. 1998 Sep;11(9):814–822. [PubMed] [Google Scholar]
  3. Bostick P. J., Chatterjee S., Chi D. D., Huynh K. T., Giuliano A. E., Cote R., Hoon D. S. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol. 1998 Aug;16(8):2632–2640. doi: 10.1200/JCO.1998.16.8.2632. [DOI] [PubMed] [Google Scholar]
  4. Bostick P. J., Hoon D. S., Cote R. J. Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer. N Engl J Med. 1998 Nov 26;339(22):1643–1644. [PubMed] [Google Scholar]
  5. Bostick P. J., Huynh K. T., Sarantou T., Turner R. R., Qi K., Giuliano A. E., Hoon D. S. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer. 1998 Dec 18;79(6):645–651. doi: 10.1002/(sici)1097-0215(19981218)79:6<645::aid-ijc16>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  6. Bostick P. J., Morton D. L., Turner R. R., Huynh K. T., Wang H. J., Elashoff R., Essner R., Hoon D. S. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol. 1999 Oct;17(10):3238–3244. doi: 10.1200/JCO.1999.17.10.3238. [DOI] [PubMed] [Google Scholar]
  7. Brugger W., Bühring H. J., Grünebach F., Vogel W., Kaul S., Müller R., Brümmendorf T. H., Ziegler B. L., Rappold I., Brossart P. Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J Clin Oncol. 1999 May;17(5):1535–1544. doi: 10.1200/JCO.1999.17.5.1535. [DOI] [PubMed] [Google Scholar]
  8. Burchill S. A., Bradbury M. F., Pittman K., Southgate J., Smith B., Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer. 1995 Feb;71(2):278–281. doi: 10.1038/bjc.1995.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carter B. A., Jensen R. A., Simpson J. F., Page D. L. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol. 2000 Feb;113(2):259–265. doi: 10.1309/7EF8-F1W7-YVNT-H8H5. [DOI] [PubMed] [Google Scholar]
  10. Chi D. D., Merchant R. E., Rand R., Conrad A. J., Garrison D., Turner R., Morton D. L., Hoon D. S. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Am J Pathol. 1997 Jun;150(6):2143–2152. [PMC free article] [PubMed] [Google Scholar]
  11. Datta Y. H., Adams P. T., Drobyski W. R., Ethier S. P., Terry V. H., Roth M. S. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol. 1994 Mar;12(3):475–482. doi: 10.1200/JCO.1994.12.3.475. [DOI] [PubMed] [Google Scholar]
  12. Finke J., Fritzen R., Ternes P., Lange W., Dölken G. An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. Biotechniques. 1993 Mar;14(3):448–453. [PubMed] [Google Scholar]
  13. Fitzgibbons P. L., Page D. L., Weaver D., Thor A. D., Allred D. C., Clark G. M., Ruby S. G., O'Malley F., Simpson J. F., Connolly J. L. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000 Jul;124(7):966–978. doi: 10.5858/2000-124-0966-PFIBC. [DOI] [PubMed] [Google Scholar]
  14. Fujie T., Mori M., Ueo H., Sugimachi K., Akiyoshi T. Expression of MAGE and BAGE genes in Japanese breast cancers. Ann Oncol. 1997 Apr;8(4):369–372. doi: 10.1023/a:1008255630202. [DOI] [PubMed] [Google Scholar]
  15. Gaugler B., Van den Eynde B., van der Bruggen P., Romero P., Gaforio J. J., De Plaen E., Lethé B., Brasseur F., Boon T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med. 1994 Mar 1;179(3):921–930. doi: 10.1084/jem.179.3.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Giuliano A. E., Dale P. S., Turner R. R., Morton D. L., Evans S. W., Krasne D. L. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995 Sep;222(3):394–401. doi: 10.1097/00000658-199509000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Giuliano A. E., Jones R. C., Brennan M., Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997 Jun;15(6):2345–2350. doi: 10.1200/JCO.1997.15.6.2345. [DOI] [PubMed] [Google Scholar]
  18. Giuliano A. E., Kirgan D. M., Guenther J. M., Morton D. L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994 Sep;220(3):391–401. doi: 10.1097/00000658-199409000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hammond M. E., Fitzgibbons P. L., Compton C. C., Grignon D. J., Page D. L., Fielding L. P., Bostwick D., Pajak T. F. College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants. Arch Pathol Lab Med. 2000 Jul;124(7):958–965. doi: 10.5858/2000-124-0958-COAPCX. [DOI] [PubMed] [Google Scholar]
  20. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol. 1994 Oct;12(10):2229–2234. doi: 10.1200/JCO.1994.12.10.2229. [DOI] [PubMed] [Google Scholar]
  21. Hoon D. S., Doi F., Giuliano A. E., Schmid P., Conrad A. J. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer. 1995 Aug 1;76(3):533–535. doi: 10.1002/1097-0142(19950801)76:3<533::aid-cncr2820760330>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  22. Hoon D. S., Sarantou T., Doi F., Chi D. D., Kuo C., Conrad A. J., Schmid P., Turner R., Guiliano A. Detection of metastatic breast cancer by beta-hCG polymerase chain reaction. Int J Cancer. 1996 Oct 21;69(5):369–374. doi: 10.1002/(SICI)1097-0215(19961021)69:5<369::AID-IJC3>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  23. Hoon D. S., Wang Y., Dale P. S., Conrad A. J., Schmid P., Garrison D., Kuo C., Foshag L. J., Nizze A. J., Morton D. L. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol. 1995 Aug;13(8):2109–2116. doi: 10.1200/JCO.1995.13.8.2109. [DOI] [PubMed] [Google Scholar]
  24. Hoon D. S., Yuzuki D., Hayashida M., Morton D. L. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J Immunol. 1995 Jan 15;154(2):730–737. [PubMed] [Google Scholar]
  25. Lambrechts A. C., Bosma A. J., Klaver S. G., Top B., Perebolte L., van' t Veer L. J., Rodenhuis S. Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells. Breast Cancer Res Treat. 1999 Aug;56(3):219–231. doi: 10.1023/a:1006261731125. [DOI] [PubMed] [Google Scholar]
  26. Lee A. H., Dublin E. A., Bobrow L. G., Poulsom R. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J Pathol. 1998 Aug;185(4):394–401. doi: 10.1002/(SICI)1096-9896(199808)185:4<394::AID-PATH117>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  27. Moinfar F., Man Y. G., Lininger R. A., Bodian C., Tavassoli F. A. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations. Am J Surg Pathol. 1999 Sep;23(9):1048–1058. doi: 10.1097/00000478-199909000-00007. [DOI] [PubMed] [Google Scholar]
  28. Mori M., Inoue H., Mimori K., Shibuta K., Baba K., Nakashima H., Haraguchi M., Tsuji K., Ueo H., Barnard G. F. Expression of MAGE genes in human colorectal carcinoma. Ann Surg. 1996 Aug;224(2):183–188. doi: 10.1097/00000658-199608000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mori M., Mimori K., Inoue H., Barnard G. F., Tsuji K., Nanbara S., Ueo H., Akiyoshi T. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995 Aug 1;55(15):3417–3420. [PubMed] [Google Scholar]
  30. Neville A. M., Bettelheim R., Gelber R. D., Säve-Söderbergh J., Davis B. W., Reed R., Torhorst J., Golouh R., Peterson H. F., Price K. N. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. J Clin Oncol. 1992 May;10(5):696–705. doi: 10.1200/JCO.1992.10.5.696. [DOI] [PubMed] [Google Scholar]
  31. Noguchi S., Aihara T., Motomura K., Inaji H., Imaoka S., Koyama H. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol. 1996 Feb;148(2):649–656. [PMC free article] [PubMed] [Google Scholar]
  32. Novaes M., Bendit I., Garicochea B., del Giglio A. Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors. Mol Pathol. 1997 Aug;50(4):209–211. doi: 10.1136/mp.50.4.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Oaks M. K., Hanson J. P., Jr, O'Malley D. P. Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: implications for MAGE immunotherapy. Cancer Res. 1994 Apr 1;54(7):1627–1629. [PubMed] [Google Scholar]
  34. Okamoto T., Kaneda Y., Yuzuki D., Huang S. K., Chi D. D., Hoon D. S. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine. Gene Ther. 1997 Sep;4(9):969–976. doi: 10.1038/sj.gt.3300490. [DOI] [PubMed] [Google Scholar]
  35. Pantel K., Cote R. J., Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst. 1999 Jul 7;91(13):1113–1124. doi: 10.1093/jnci/91.13.1113. [DOI] [PubMed] [Google Scholar]
  36. Prasad M. L., Osborne M. P., Hoda S. A. Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast. Anat Pathol. 1998;3:209–232. [PubMed] [Google Scholar]
  37. Reyes C. V., Thompson K. S., Jensen J. D., Choudhury A. M. Metastasis of unknown origin: the role of fine-needle aspiration cytology. Diagn Cytopathol. 1998 May;18(5):319–322. doi: 10.1002/(sici)1097-0339(199805)18:5<319::aid-dc1>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  38. Richard F., Pacyna-Gengelbach M., Schlüns K., Fleige B., Winzer K. J., Szymas J., Dietel M., Petersen I., Schwendel A. Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer. 2000 May 20;89(3):305–310. [PubMed] [Google Scholar]
  39. Russo V., Traversari C., Verrecchia A., Mottolese M., Natali P. G., Bordignon C. Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int J Cancer. 1995 Jun 22;64(3):216–221. doi: 10.1002/ijc.2910640313. [DOI] [PubMed] [Google Scholar]
  40. Schoenfeld A., Luqmani Y., Smith D., O'Reilly S., Shousha S., Sinnett H. D., Coombes R. C. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res. 1994 Jun 1;54(11):2986–2990. [PubMed] [Google Scholar]
  41. Sinha P. S., Bendall S., Bates T. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers? Eur J Surg Oncol. 2000 Dec;26(8):733–737. doi: 10.1053/ejso.2000.0994. [DOI] [PubMed] [Google Scholar]
  42. Thurner B., Haendle I., Röder C., Dieckmann D., Keikavoussi P., Jonuleit H., Bender A., Maczek C., Schreiner D., von den Driesch P. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med. 1999 Dec 6;190(11):1669–1678. doi: 10.1084/jem.190.11.1669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Toikkanen S., Pylkkänen L., Joensuu H. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer. 1997;76(9):1234–1240. doi: 10.1038/bjc.1997.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Turner R. R., Ollila D. W., Krasne D. L., Giuliano A. E. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg. 1997 Sep;226(3):271–278. doi: 10.1097/00000658-199709000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Turner R. R., Ollila D. W., Stern S., Giuliano A. E. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol. 1999 Mar;23(3):263–267. doi: 10.1097/00000478-199903000-00003. [DOI] [PubMed] [Google Scholar]
  46. Weber J. S., Hua F. L., Spears L., Marty V., Kuniyoshi C., Celis E. A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma. J Immunother. 1999 Sep;22(5):431–440. doi: 10.1097/00002371-199909000-00007. [DOI] [PubMed] [Google Scholar]
  47. Xu X., Roberts S. A., Pasha T. L., Zhang P. J. Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med. 2000 Sep;124(9):1310–1313. doi: 10.5858/2000-124-1310-UCIONN. [DOI] [PubMed] [Google Scholar]
  48. Yun K., Gunn J., Merrie A. E., Phillips L. V., McCall J. L. Keratin 19 mRNA is detectable by RT-PCR in lymph nodes of patients without breast cancer. Br J Cancer. 1997;76(8):1112–1113. doi: 10.1038/bjc.1997.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Zeng Z., Melamed J., Symmans P. J., Cangiarella J. F., Shapiro R. L., Peralta H., Symmans W. F. Benign proliferative nipple duct lesions frequently contain CAM 5.2 and anti-cytokeratin 7 immunoreactive cells in the overlying epidermis. Am J Surg Pathol. 1999 Nov;23(11):1349–1355. doi: 10.1097/00000478-199911000-00005. [DOI] [PubMed] [Google Scholar]
  50. Zippelius A., Kufer P., Honold G., Köllermann M. W., Oberneder R., Schlimok G., Riethmüller G., Pantel K. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol. 1997 Jul;15(7):2701–2708. doi: 10.1200/JCO.1997.15.7.2701. [DOI] [PubMed] [Google Scholar]
  51. van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., Van den Eynde B., Knuth A., Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991 Dec 13;254(5038):1643–1647. doi: 10.1126/science.1840703. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES